Close

Drug May Help with Common Form of Vision Loss

marzo 30, 2017 Lifestyle

An experimental drug reduces eye damage in people with a common form of vision loss for which there is currently no available treatment, a new study finds.

The new research sought to treat age-related macular degeneration (AMD), the leading cause of vision loss in industrialized countries, according to the World Health Organization. The disease damages the macula, a tiny spot near the center of the retina, the light-sensitive part of the eye. The result is blurriness or a loss of vision straight ahead in a person’s field of view, which can have a devastating impact on many daily activities, such as reading, driving or recognizing faces.

The new study included 129 participants ages 60 to 89 in the United States and Germany. All of the participants had a particular type of AMD called geographic atrophyAMD, or “dry AMD.” In the 18-month trial, the participants who were given monthly injections of a drug called lampalizumab had a 20 percent reduction, on average, in the size of the area of the retina that is affected by the disease, compared with the control group that was given a placebo injection. [Eye Tricks: Gallery of Visual Illusions]

2 Comments on “Drug May Help with Common Form of Vision Loss

admin
marzo 30, 2017 at 11:09 am

Pregnancy can also lower vitamin B12 levels, as can hyperthyroidism (overactive thyroid) if it causes the person to produce too much body heat, according to the NIH.

Rispondi
admin
giugno 27, 2017 at 12:39 pm

Pregnant or breastfeeding women who do not get enough vitamin B12 may cause their babies to have low vitamin B12 levels.

Rispondi

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *